Proteomic analysis of a podocyte vesicle-enriched fraction from human normal and pathological urine samples

Proteomics - Clinical Applications

Volumn 2, Issue 7-8, 2008, Pages 1008-1018

  Lescuyer, Pierre ^a   Pernin, Agnès ^a   Hainard, Alexandre ^a   Bigeire, Caty ^a   Burgess, Jennifer A ^a   Zimmermann Ivol, Catherine ^a   Sanchez, Jean Charles ^a   Schifferli, Jürg A ^b   Hochstrasser, Denis F ^a   Moll, Solange ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Biomarkers; Glomerulopathies; Podocytes; Serum paraoxonase arylesterase 1 (PON 1); Urine

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CELL PROTEIN; DERMCIDIN; GLUTAMYL AMINOPEPTIDASE; MEGALIN; MEMBRANE PROTEIN; PROSTASIN; TAMM HORSFALL GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NUCLEOTIDE SEQUENCE; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS;

EID: 50849094873     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800033     Document Type: Article

References (41)

1. Pieper, R., Gatlin, C. L., McGrath, A. M. Makusky, A. J. et al., Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
2. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
3. Sun, W., Li, F., Wu, S., Wang, X. et al., Human urine proteome analysis by three separation approaches. Proteomics 2005, 5, 4994-5001.
4. Wang, L., Li, F., Sun, W., Wu, S. et al., Concanavalin A-captured glycoproteins in healthy human urine. Mol. Cell. Proteomics 2006, 5, 560-562.
5. Castagna, A., Cecconi, D., Sennels, L., Rappsilber, J. et al., Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 2005, 4, 1917-1930.
6. Adachi, J., Kumar, C., Zhang, V., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
7. Pascual, M., Steiger, G., Sadallah, S., Paccaud, J. P. et al., Identification of membrane-bound CR1 (CD35) in human urine: Evidence for its release by glomerular podocytes. J. Exp. Med. 1994, 179, 889-899.
8. Hara, M., Yanagihara, T., Kihara, I., Higashi, K. et al., Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte Injury. J. Am. Soc. Nephrol. 2005, 16, 408-416.
9. Cheruvanky, A., Zhou, H., Pisitkun,T., Kopp, J. B. et al., Rapid isolation of urinary exosomal biomarkers using a nano-membrane ultrafiltration concentrator. Am. J. Physiol. Renal Physiol. 2007, 292, F1657-1661.
10. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193., 265-275.
11. Quadri, R. A., Schifferli, J. A., Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes. Scand. J. Immunol. 1992, 36, 125-130.
12. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354.
13. Blum, H., Beier, H., Gross, H. J., Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8, 93-99.
14. Gharahdaghi, F., Weinberg, C. R., Meagher, D. A., Imai, B. S., Mische, S. M., Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20, 601-605.
15. Scherl, A., Coute, Y., Deon, C., Calle, A. et al., Functional proteomic analysis of human nucleolus, Mol. Biol. Cell 2002, 13, 4100-4109.
16. Burgess, J. A., Lescuyer, P., Hainard, A., Burkhard, P. R. et al., Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid. J Proteome Res. 2 2006, 5, 1674-1681.
17. Liu, T., Qian, W. J., Gritsenko, M. A., Camp, D. G. 2nd et al., Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res.2005, 4, 2070-2080.
18. de Sain-van der Velden, M. G., Rabelink, T. J., Reijngoud, D. J., Gadellaa, M. M. et al., Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int. 1998, 54, 530-535.
19. Vaziri, N. D., Gonzales, E. C., Shayestehfar, B., Barton, C. H., Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J. Lab. Clin. Med. 1994, 124, 118-124.
20. Tencer, J., Torffvit, O., Thysell, H., Rippe, B., Grubb, A., Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note. Kidney Int. 1998, 54, 2098-2105.
21. Ito, S., Usami, A., Yamazaki, M., Shibata, A., A radioimmunometric assay for urinary alpha 2-macroglobulin. Tohoku J. Exp. Med. 1995, 176, 137-147.
22. Lisowska-Myjak, B., AAT as a diagnostic tool. Clin. Chim. Acta 2005, 352, 1-13.
23. Sharma, K., Lee, S., Han, S., Lee, S. et al., Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005, 5, 2648-2655.
24. Barisoni, L., Kopp, J. B., Update in podocyte biology: Putting one's best foot forward. Curr. Opin. Nephrol. Hypertens. 2003, 12, 251-258.
25. Ransom, R. F., Vega-Warner, V., Smoyer, W. E., Klein, J., Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int. 2005, 67, 1275-1285.
26. Viney, R. L., Morrison, A. A., van den Heuvel, L. P., Ni, L. et al., A proteomic investigation of glomerular podocytes from a Denys-Drash syndrome patient with a mutation in the Wilms tumour suppressor gene WT1. Proteomics 2007, 7, 804-815.
27. Kerjaschki, D., Schulze, M., Binder, S., Kain, R. et al., Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J. Immunol. 1989, 143, 546-552.
28. Brenchley, P. E., Coupes, B., Short, C. D., O'Donoghue, D. J. et al., Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int. 1992, 41, 933-937.
29. Ogrodowski, J. L., Hebert, L. A., Sedmak, D., Cosio, F. G. et al., Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int. 1991, 40, 1141-1147.
30. Fournier, T., Medjoubi, N. N., Porquet, D., Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482, 157-171.
31. Arai, H., Tomizawa, S., Maruyama, K., Seki, Y., Kuroume, T., Reversed-phase high-performance liquid chromatography for analysis of urinary proteins: Diagnostic significance of alpha 1-acid glycoprotein. Nephron 1994, 66, 278-284.
32. Kalmovarin, N., Friedrichs, W. E., O'Brien, H. V., Linehan, L. A. et al., Extrahepatic expression of plasma protein genes during inflammation. Inflammation 1991, 15, 369-379.
33. Hjalmarsson, C., Lidell, M. E., Haraldsson, B., Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis. Nephrol. Dial. Transplant. 2006, 21, 1223-1230.
34. Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., La Du, B. N., The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33, 498-507.
35. Reddy, S. T., Wadleigh, D. J., Grijalva, V., Ng, C. et al., Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 542-547.
36. Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S. et al., Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 2001, 276, 44444-44449.
37. James, R. W., A long and winding road: Defining the biological role and clinical importance of paraoxonases. Clin. Chem. Lab. Med. 2006, 44, 1052-1059.
38. Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N. et al., The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 2005, 38, 153-163.
39. Khersonsky, O., Tawfik, D. S., Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry 2005, 44, 6371-6382.
40. Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y. et al., Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 2005, 46, 1239-1247.
41. Rodrigo, L., Hernandez, A. F., Lopez-Caballero, J. J., Gil, F., Pla, A., Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem. Biol, Interact. 2001, 137, 123-137.